| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219835 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 10 Pages |
Abstract
Our study results indicate that dose-escalated EBRT has been widely adopted by radiation oncologists treating prostate cancer in the United States. The proportion of patients receiving dose-escalated EBRT increased nearly 20% between 2006 and 2011. We observed high utilization rates of dose-escalated EBRT within all disease risk groups. Adoption of intensity modulated radiation therapy was strongly associated with use of dose-escalated treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Samuel MD, Nandita PhD, Kaitlin MS, Marc MD, Robert MD, Justin E. MD,